Melanoma

Immunotherapy is new revolution in cancer fight

Immunotherapy has made great strides against cancers like melanoma that were once believed incurable, though scientists still do not understand why it works well in some cases but not others.

Jun 02, 2014
popularity 5 / 5 (4) | comments 1

Preventable skin cancer up in Canada, study says

Melanoma cases are rising in Canada even though most other cancer rates are falling, a leading anti-cancer organization warned Wednesday, blaming tanning beds and slipping sunscreen use outdoors.

May 28, 2014
popularity not rated yet | comments 0

Melanoma detection enhanced with blood biomarkers

The need for invasive skin biopsies could be reduced extensively with Edith Cowan University researchers working on ways to detect melanoma in early stages, using a blood test in conjunction with visual scans.

May 13, 2014
popularity 5 / 5 (1) | comments 0

Monitor for sunburn risk goes on sale

A monitor developed at the University of Strathclyde in Glasgow for preventing the risk of over exposure to the sun is now available for sale online.

May 08, 2014
popularity not rated yet | comments 1

Skin cancer rates five times higher than in 70s

(Medical Xpress)—The rates of people diagnosed with malignant melanoma, the most serious form of skin cancer, are now five times higher than 40 years ago, according to figures announced by Cancer Research ...

Apr 23, 2014
popularity 3.3 / 5 (3) | comments 0

AACR: ICMgp100 tolerated, active in advanced melanoma

(HealthDay)—An affinity-enhanced T cell receptor specific for the human leukocyte antigen-A2 restricted melanoma gp 100 peptide fused to an anti-CD3 antibody fragment, IMCgp100, seems promising for advanced ...

Apr 09, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

Some people may be pre-wired to be bilingual

(HealthDay)—Some people's brains seem pre-wired to acquire a second language, new research suggests. But anyone who tries to move beyond their mother tongue will likely gain a brain boost, the small study ...

Ebola vaccine promising in first human trials

Researchers say they are one step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

Team finds an off switch for pain

In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have d ...